Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -124,697 | -96,015 | -85,981 | -72,188 | -88,290 |
| Depreciation Amortization | -1,137 | 173 | 2,641 | 4,081 | 3,902 |
| Accounts receivable | N/A | N/A | 110 | -110 | N/A |
| Accounts payable and accrued liabilities | 2,205 | -764 | -5,246 | 1,209 | -3,431 |
| Other Working Capital | 2,850 | -8,868 | -3,689 | -23,041 | 16,160 |
| Other Operating Activity | 20,767 | 11,294 | -5,812 | 12,285 | 15,060 |
| Operating Cash Flow | $-100,012 | $-94,180 | $-97,977 | $-77,764 | $-56,599 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,437 | 11,204 | 30,049 | -89,805 | 7,499 |
| PPE Investments | -649 | -1,515 | -2,415 | -1,281 | -899 |
| Net Acquisitions | N/A | N/A | 31,523 | N/A | N/A |
| Investing Cash Flow | $-16,086 | $9,689 | $59,157 | $-91,086 | $6,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,143 | N/A | N/A |
| Debt Repayment | -473 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 127,684 | 2,974 | 72,573 | 134,919 | 132,490 |
| Other Financing Activity | -4,774 | 148 | 115 | 66 | -3,790 |
| Financing Cash Flow | $122,437 | $3,122 | $74,831 | $134,985 | $128,700 |
| Beginning Cash Position | 75,848 | 157,217 | 121,206 | 155,071 | 76,370 |
| End Cash Position | 82,187 | 75,848 | 157,217 | 121,206 | 155,071 |
| Net Cash Flow | $6,339 | $-81,369 | $36,011 | $-33,865 | $78,701 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,012 | -94,180 | -97,977 | -77,764 | -56,599 |
| Capital Expenditure | -654 | -1,515 | -3,015 | -1,281 | -899 |
| Free Cash Flow | -100,666 | -95,695 | -100,992 | -79,045 | -57,498 |